Matches 1 - 50 out of 187 1 2 3 4 >


Match Document Document Title
US20100158996 ESTER COMPOUND AND MEDICAL USE THEREOF  
A novel therapeutic agent for hyperlipidemia, which is an ester compound represented by the formula (1″) (wherein R1 and R2 are each hydrogen atom or optionally substituted aryl, etc.;X is —COO—...
US20090291948 SULFONAMIDE PERI-SUBSTITUTED BICYCLICS FOR OCCLUSIVE ARTERY DISEASE  
Acyl sulfonamide, peri-substituted, fused bicyclic ring compounds useful for the treatment or prophylaxis of a prostaglandin-mediated disease or condition are disclosed. The compounds are of the...
US20170128578 PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES  
The present invention provides for a derivative of monoterpene or sesquiterpene, such as a perillyl alcohol derivative. For example, the perillyl alcohol derivative may be a perillyl alcohol...
US20140051689 Polycyclic Agents for the Treatment of Respiratory Syncytial Virus Infections  
Compounds of formula (I), and their use as in the treatment of infections involving viruses of the Pneumovirinae sub-family (RSV) are disclosed. In the formula ring (A) may be phenyl, pyridyl...
US20130004481 ANTICANCER THERAPY  
The invention describes anti-cancer therapies comprising using dual Aurora kinase/MEK inhibitors as described herein.
US20100166674 TRANSDERMAL DELIVERY RATE CONTROL USING AMORPHOUS PHARMACEUTICAL COMPOSITIONS  
A pharmaceutical composition for transdermal delivery comprising one or more physiologically active agents;one or more dermal penetration enhancers; anda volatile pharmaceutically acceptable...
US20080090803 FATTY ALCOHOL DRUG CONJUGATES  
The invention provides conjugates of fatty alcohols and pharmaceutical agents useful in treating cancer, viruses, psychiatric disorders. Compositions, pharmaceutical preparations, and methods of...
US20070027083 Human growth hormone aqueous formulation  
A stable pharmaceutically acceptable aqueous formulation containing human growth hormone, a buffer, a non-ionic surfactant, and, optionally, a neutral salt, mannitol, or, a preservative, is...
US20160082005 PROCESS OF MAKING AND USING PHARMACEUTICAL FORMULATIONS OF ANTINEOPLASTIC AGENTS  
In its several embodiments, this invention discloses a pharmaceutical formulation comprising at least one antineoplastic agent or a pharmaceutically acceptable salt thereof, and at least one...
US20140088166 PROCESS OF MAKING AND USING PHARMACEUTICAL FORMULATIONS OF ANTINEOPLASTIC AGENTS  
In its several embodiments, this invention discloses a pharmaceutical formulation comprising at least one antineoplastic agent or a pharmaceutically acceptable salt thereof, and at least one...
US20120277215 Organic Compounds  
The present invention provides a compound of formula I: Said compound is inhibitor of aldosterone synthase and aromatase, and thus can be employed for the treatment of a disorder or disease...
US20090311235 Use of Polymeric Materials with Other Substances for Improved Performance  
Methods of enabling or improving the ability of a hydrogel to swell in the stomach of an animal and/or increasing the amount of time said hydrogel remains swollen in the stomach are described...
US20070065374 Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations  
Nanoparticulate compositions comprising a corticosteroid and a leukotriene receptor antagonist are described. The compositions are useful in the prophylaxis and chronic treatment of asthma in...
US20060029585 Methods for reducing morbidity  
Various compositions containing transfer factor in combination with nutraceuticals are provided including transfer factor in combination with zinc and essential fatty acids and transfer factor in...
US20080161374 Pyrazole compounds and uses related thereto  
Substituted pyrazoles are provided that are useful for the treatment of, for example, diabetes, obesity and metabolic syndrome.
US20060183737 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists  
Retinoids with retinoid receptor antagonistic activity, pharmaceutically acceptable salts and pharmaceutically acceptable hydrolyzable esters thereof, have been found efficacious in treating...
US20050227967 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists  
Retinoids with retinoid receptor antagonistic activity, pharmaceutically acceptable salts and pharmaceutically acceptable hydrolyzable esters thereof, have been found efficacious in treating...
US20050214385 Chromium/biotin treatment of dyslipidemia and diet-induced post prandial hyperglycemia  
A method for treating dyslipidemia and/or post prandial hyperglycemia by administering a combination of a chromium complex and biotin to an individual in need thereof is disclosed. The two...
US20160030394 Mazindol Combination In The Treatment Of Attention-Deficit/Hyperactivity  
The present invention relates to the field of human health, and more particularly to the treatment of attention deficit/hyperactivity disorder (ADHD) with mazindol. The latter can be administered...
US20120308668 MAZINDOL COMBINATION IN THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY  
The present invention relates to the field of human health, and more particularly to the treatment of attention deficit/hyperactivity disorder (ADHD) with mazindol. The latter can be administered...
US20120219541 Therapeutic Compositions Comprising Monoterpenes  
This invention provides a compositions for transport of a therapeutic agent. The compositions contain a therapeutic agent and a monoterpene or an analog thereof. In one aspect, the monoterpene is...
US20050222224 p53 Inhibitors and therapeutic use of the same  
The therapeutic use of temporary p53 inhibitors in the treatment of p53-mediated diseases, conditions, and injuries is disclosed.
US20050153371 Conjugated small molecules  
Provided herein are linker compounds and conjugates that include the linker compounds. In one embodiment, the linker compounds comprise 2 or 3 residues of 6-aminohexanoic acid and optionally 7-10...
US20110183009 Mazindol Combination In The Treatment Of Attention-Deficit/Hyperactivity  
The present invention relates to the field of human health, and more particularly to the treatment of attention deficit/hyperactivity disorder (ADHD) with mazindol. The latter can be administered...
US20100323002 INHIBITION OF MELANOGENESIS AND MELANOMA METASTASIS WITH P-AMINO BENZOIC ACID (PABA)  
The present invention relates to the inhibition of melanogenesis with para-aminobenzoic acid (PABA) and its use in treating melanotic cancer.
US20070135376 METHOD TO REDUCE OXIDATIVE DAMAGE AND IMPROVE MITOCHONDRIAL EFFICIENCY  
Methods for the reduction of mitochondrial oxidative damage and improved mitochondrial efficiency in an animal by administration of medium chain triglycerides or prodrug of medium chain...
US20160176883 Forms and salts of a dihydropyrrolo[1,2c]imidazolyl aldosterone synthase or aromatase inhibitor  
The invention relates to a phosphate salt or a nitrate salt of 4-(R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl-3-fluoro-be nzonitrile, especially in crystalline form, and specific forms of these...
US20100119482 Treatment of Conditions Through Modulation of the Autonomic Nervous System During at Least One Predetermined Menstrual Cycle Phase  
Methods are provided for treating a subject for a condition. In accordance with the subject methods, at least a portion of a subject's autonomic nervous system is modulated during at least one...
US20150038501 INHIBITORS OF HCV NS5A  
Provided herein are compounds, pharmaceutical compositions and combination therapies for inhibition of hepatitis C.
US20110086113 CANNABINOIDS IN COMBINATION WITH NON-CANNABINOID CHEMOTHERAPEUTIC AGENTS (E.G. SERM OR ALKYLATING AGENTS)  
The invention relates to the use of one or more cannabinoids, particularly THC and/or CBD in combination with a non-cannabinoid chemotherapeutic agent in the manufacture of a medicament for use in...
US20100028469 Extracts of Cranberry and Methods of Using Thereof  
The present disclosure relates in part to extracts of cranberry (Vaccinium macrocarpon) comprising an enriched amount of certain compounds having anti-infective activity, e.g. antibacterial and/or...
US20050048012 Use of biotin or a biotin derivative for skin lightening purposes and for the treatment of senile lentigines  
The present invention relates to the use of biotin and biotin derivatives alone, or with vitamin C or a derivative thereof, for the preparation of a cosmetic composition or of a pharmaceutical...
US20160074390 HUMAN DOSING OF PHOSPHATASE INHIBITOR  
The present invention provides a method of inhibiting protein phosphatase 2A (PP2A) in a human subject in need thereof comprising administering to the subject an amount of from 0.1 mg/m2 to 5...
US20140205672 RELEASE CONTROL COMPOSITIONS  
A controlled release composition for oral administration, which comprises a physiologically active substance which is a compound represented by the formula: wherein n is an integer of 1 to 3, and...
US20120282179 Methods of Using C-Met Modulators  
Methods of treating cancer by administering a compound of Formula I, or a pharmaceutically acceptable salt or solvate thereof, in combination with other cancer treatments are described, wherein R1...
US20080268038 Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength  
Provided are compositions and methods for increasing diet induced thermogenesis. Typically, the compositions are comprised of L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine,...
US20080058349 New Compounds 318  
This invention relates to novel compounds having the structural formula I below: and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a...
US20050176796 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents  
Compounds which are tricyclic pyrazole derivatives and analogues thereof, as set forth in the specification, or pharmaceutically acceptable salts thereof, together with pharmaceutical compositions...
US20060228325 Water soluble multi-biotin-containing compounds  
Water-soluble discrete multi-biotin-containing compounds with at least three (3) biotin moieties are disclosed. The water-soluble biotin-containing compounds may additionally comprise one or more...
US20160039731 Pharmaceutical Compositions Comprising Deuterium-Enriched Perillyl Alcohol, Iso-Perillyl Alcohol and Derivatives Thereof  
The present invention, provides for a deuterium-enriched monoterpene or sesquiterpene such as perillyl alcohol, or a deuterium-enriched isomer or analog of monoterpenes or sesquiterpenes, such as...
US20130331384 FIRMOCIDIN, AN ANTIMICROBIAL MOLECULE PRODUCED BY STAPHYLOCOCCUS EPIDERMIDIS  
The disclosure provides for novel antimicrobial agents, methods of making, and methods of use thereof.
US20130030237 POTENTIATION OF ANTI-CANCER ACTIVITY THROUGH COMBINATION THERAPY WITH BER PATHWAY INHIBITORS  
Provided herein are pharmaceutical compositions and methods of treating cancer wherein the cytotoxic activity of an anticancer agent is potentiated by the combination of base excision repair (BER)...
US20130011483 FORMULATIONS OF MAZINDOL  
Formulations of mazindol having superior stability and methods of administering same are provided. The formulations may be immediate, enhanced, or otherwise delayed release formulations of mazindol.
US20120316150 AMIDE COMPOUNDS USEFUL IN THERAPY  
A compound of Formula (I), or a pharmaceutically acceptable salt or solvate thereof, wherein, R1, R2, R3, R4, R5 and R6 are as defined herein: and compositions, processes for the preparation, and...
US20060004044 3-glyoxylamideindoles for treating cancer  
Disclosed is an anti-cancer compound represented by Structural Formula (I): The variables in Structural Formula (I) are described hereinbelow. Also disclosed is a pharmaceutical composition...
US20150290209 FIRMOCIDIN, AN ANTIMICROBIAL MOLECULE PRODUCED BY STAPHYLOCOCCUS EPIDERMIDIS  
The disclosure provides for novel antimicrobial agents, methods of making, and methods of use thereof.
US20130029964 [5, 6] HETEROCYCLIC COMPOUND  
An object of the present invention is to provide a novel low molecular weight compound exhibiting an osteogenesis-promoting action. This object is achieved by a compound having the general formula...
US20080269217 Melanocortin-4 receptor binding compounds and methods of use thereof  
Provided are MC4-R binding compounds of the formula XVII: wherein L2 is a linker group, and P1, P2, P3, P4, Z1, Z2, Z3, Z4, Z5, t, s, and R are as described in the specification. Methods of using...
US20070292493 Pharmaceutical composition and method for the transdermal delivery of calcium  
The present invention relates to a method and transdermal pharmaceutical composition for preventing or reducing the likelihood of calcium deficiency or imbalances caused by calcium deficiency. The...
US20060275909 Nutrition formulations and methods of providing nutrition formulations  
Nutritional compositions such as total parenteral nutrition (TPN) compositions and processes of preparing same are disclosed. The advantage of the present invention lies in its ability to tailor...

Matches 1 - 50 out of 187 1 2 3 4 >